Abstract:The gene editing technology enables cutting or/and inserting the target gene precisely. The CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated protein 9) system relies on two major elements, a guide RNA (gRNA) that recognizes a specific DNA sequence, and a nuclease Cas9 that cuts the target DNA and creates double-strand breaks (DSBs). Among a few gene-editing technologies available, CRISPR/Cas9 system has showed tremendous advantages over the others, mainly due to high efficiency of Cas9 and simple design of gRNA. As a versatile and powerful tool for genome engineering, the CRISPR/Cas9 technology has been used to generate genetically modified mice with unprecedented simplicity and speed, simply by timed delivery of Cas9/gRNA ribonucleoproteins (RNPs) into pronuclear-stage zygotes. The modified protocol introduces Cas9 protein instead of Cas9 mRNA by rapid electroporation, which enables the gene editing occurring before the first replication of the mouse genome, thus generating non-mosaic mutant embryos. Furthermore, it could be used to produce multiple gene mutations in a single mouse by co-delivering several gRNAs targeted to different genes. Herein, we summarize current applications of CRISPR/Cas9 technology in the field of neuroscience, and aim to provide concise information and perspectives for better utilizing this technology. In brain research, the CRISPR/Cas9 system can be applied either at the one-cell stage of the fertilized eggs in the form of Cas9/gRNA ribonucleoproteins, or at the stage of embryos or adults in the form of plasmid DNA or the viral vectors (commonly AAV variants) respectively. To deliver the system specifically into the developmental or adult brain, in utero electroporation, or stereotaxic injection is commonly employed. Several reports show that AAV-assisted Cas9/gRNA system could achieve a satisfied efficiency for genome editing in the adult mouse brain, but results vary depending on Cas9 activity, gRNA design, detection methods, and the condition of endogenous DNA repair mechanisms. Remarkable efforts have also been made to enhance the incidence of homology-directed repair for precise gene modifications. Regarding therapeutic genome editing, a couple of recent in vivo studies demonstrate that CRISPR/Cas9 system could contract or remove disease-causing alleles in animal models of certain hereditary diseases such as retinitis pigmentosa and Huntington′s disease, raising hope for translating therapeutic genome editing to clinical patients. In addition, we discuss major challenges and critical improvements for this technology, including a few modifications for promoting precise editing in non-dividing cells in the case of adult brain. In the future, application of CRISPR/Cas9 technology would be enhanced greatly in neuroscience by developing cell type-specific, timed delivery system in vivo and by combining with other powerful techniques for dissecting brain neural circuits in health and disease.

Combination of the clustered regularly interspaced short palindromic repeats (CRISPR)-associated 9 technique with the piggybac transposon system for mouse in utero electroporation to study cortical development.

Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model

CRISPR/Cas9 as Tool for Functional Study of Genes Involved in Preimplantation Embryo Development

One-Step piggyBac Transposon-Based CRISPR/Cas9 Activation of Multiple Genes.

[Establishment of a System for Regulating the Gene Expression of Embryonic Mouse Cerebral Cortex Neural Stem Cells by in Utero Electroporation].

An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing

Precise Allele-Specific Genome Editing by Spatiotemporal Control of CRISPR-Cas9 Via Pronuclear Transplantation

Efficient Genome Editing of Mice by CRISPR Electroporation of Zygotes

Large genomic fragment deletion and functional gene cassette knock-in via Cas9 protein mediated genome editing in one-cell rodent embryos

Introducing gene deletions by mouse zygote electroporation of Cas12a/Cpf1

CRISPR-Cas9-mediated Genome Editing in One Blastomere of Two-Cell Embryos Reveals a Novel Tet3 Function in Regulating Neocortical Development

Study of dendritic spines and axonal projection in mouse cerebral cortex using in utero electroporation

Simplified pipelines for genetic engineering of mammalian embryos by CRISPR-Cas9 electroporation†

CRISPR-mediated Loss of Function Analysis in Cerebellar Granule Cells Using in Utero Electroporation-based Gene Transfer

Strategy for Applying CRISPR/Cas9 Gene Editing Technology in Neuroscience

Optimization of a CRISPR/Cas9-mediated Knock-in Strategy at the Porcine Rosa26 Locus in Porcine Foetal Fibroblasts

In Utero Electroporation(IUE) and mouse genetic model approach to assess PITP‐dependent inositol lipid signaling in NSC pool maintenance in embryonic brain

Efficient Inversions and Duplications of Mammalian Regulatory DNA Elements and Gene Clusters by CRISPR/Cas9

Efficient CRISPR/Cas9-mediated biallelic gene disruption and site-specific knockin after rapid selection of highly active sgRNAs in pigs

One-step Generation of Triple Gene-Targeted Pigs Using CRISPR/Cas9 System

One-step in Vivo Gene Knock-out in Porcine Embryos Using Recombinant Adeno-Associated Viruses